CathVision

Traditional EP recording systems are expensive, limited in capability and deliver substandard electrogram signals, creating an unacceptable status quo that reduces the ability to effectively diagnose and determine therapy for complex cardiac arrhythmia.

CHANGING THE STANDARD

Learn More

CathVision is committed to enhancing clinical decision making and patient outcomes in the EP lab through the advancement of EP recording technologies.

EMPOWERING ELECTROPHYSIOLOGISTS WITH MODERN TECHNOLOGY

Learn More

CathVision’s innovative EP recording technology – the ECGenius™ System – is enhancing the quality of cardiac electrical signals to improve the diagnosis, characterization and treatment of the most common heart rhythm disorders.

THE ECGENIUS™ SYSTEM

Artificial Intelligence Analytics

CathVision is developing a suite of AI-based analytic tools – CARDIALYTICS™ – designed specifically to provide unprecedented levels of automated analyses during the diagnosis and treatment of complex atrial arrhythmia including atrial fibrillation.

Learn More

CARDIALYTICS™

Learn More

ADVANCING ARRHYTHMIA CARE

At CathVision, we are committed to the development of innovative technologies that provide electrophysiologists with unprecedented levels of automated analyses to improve the treatment of complex cardiac arrhythmia.

1 / 5

Pristine data

See what you’ve been missing.

Precise Analytics

Real-time, automated, AI-based algorithms physicians can trust.

Powerful Decisions

Comprehensive, clinical decision-making simplified.

EP RECORDING. ENHANCED.

It’s time to upgrade the EP lab.

ECGenius™ System represents an evolution in cardiac signal acquisition, interpretation, and therapy support, creating unprecedented opportunities for the integration of AI-based algorithms.

ABOUT CathVision

CathVision’s mission is to help physicians cure cardiac arrhythmia. Committed to empowering physicians to make more informed clinical decisions in the EP lab, CathVision is redefining the necessity of exceptional cardiac electrical signals to diagnose, characterize and treat the most common heart rhythm disorders. The company is focused on developing electrophysiology solutions centered around an innovative EP recording system and AI-based analytic tools.